Adicet Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Adicet Bio and other ETFs, options, and stocks.About ACET
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells.
CEOChen Schor
CEOChen Schor
Employees152
Employees152
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2014
Founded2014
Employees152
Employees152
ACET Key Statistics
Market cap82.74M
Market cap82.74M
Price-Earnings ratio-0.42
Price-Earnings ratio-0.42
Dividend yield—
Dividend yield—
Average volume2.09M
Average volume2.09M
High today$0.56
High today$0.56
Low today$0.5317
Low today$0.5317
Open price$0.535
Open price$0.535
Volume2.15M
Volume2.15M
52 Week high$1.12
52 Week high$1.12
52 Week low$0.4471
52 Week low$0.4471
Stock Snapshot
Adicet Bio(ACET) stock is priced at $0.54, giving the company a market capitalization of 82.74M. It carries a P/E multiple of -0.42.
On 2025-12-06, Adicet Bio(ACET) stock traded between a low of $0.53 and a high of $0.56. Shares are currently priced at $0.54, which is +1.6% above the low and -3.6% below the high.
The Adicet Bio(ACET)'s current trading volume is 2.15M, compared to an average daily volume of 2.09M.
During the past year, Adicet Bio(ACET) stock moved between $0.45 at its lowest and $1.12 at its peak.
During the past year, Adicet Bio(ACET) stock moved between $0.45 at its lowest and $1.12 at its peak.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ACET. This list is generated using Robinhood data, and it’s not a recommendation.